175 related articles for article (PubMed ID: 31700166)
1. Inhibition of UCHL1 by LDN-57444 attenuates Ang II-Induced atrial fibrillation in mice.
Bi HL; Zhang YL; Yang J; Shu Q; Yang XL; Yan X; Chen C; Li Z; Li HH
Hypertens Res; 2020 Mar; 43(3):168-177. PubMed ID: 31700166
[TBL] [Abstract][Full Text] [Related]
2. Novel Role for the Immunoproteasome Subunit PSMB10 in Angiotensin II-Induced Atrial Fibrillation in Mice.
Li J; Wang S; Bai J; Yang XL; Zhang YL; Che YL; Li HH; Yang YZ
Hypertension; 2018 May; 71(5):866-876. PubMed ID: 29507100
[TBL] [Abstract][Full Text] [Related]
3. Blockage of UCHL1 activity attenuates cardiac remodeling in spontaneously hypertensive rats.
Han X; Zhang YL; Fu TT; Li PB; Cong T; Li HH
Hypertens Res; 2020 Oct; 43(10):1089-1098. PubMed ID: 32541849
[TBL] [Abstract][Full Text] [Related]
4. Neferine mitigates angiotensin II-induced atrial fibrillation and fibrosis via upregulation of Nrf2/HO-1 and inhibition of TGF-β/p-Smad2/3 pathways.
Jiang XX; Zhang R; Wang HS
Aging (Albany NY); 2024 May; 16(10):8630-8644. PubMed ID: 38775722
[TBL] [Abstract][Full Text] [Related]
5. Immunoproteasome Subunit β5i Promotes Ang II (Angiotensin II)-Induced Atrial Fibrillation by Targeting ATRAP (Ang II Type I Receptor-Associated Protein) Degradation in Mice.
Li J; Wang S; Zhang YL; Bai J; Lin QY; Liu RS; Yu XH; Li HH
Hypertension; 2019 Jan; 73(1):92-101. PubMed ID: 30571551
[TBL] [Abstract][Full Text] [Related]
6. Administration of USP7 inhibitor p22077 alleviates Angiotensin II (Ang II)-induced atrial fibrillation in Mice.
Wang Y; Gu YH; Ren KW; Xie X; Wang SH; Zhu XX; Wang L; Yang XL; Bi HL
Hypertens Res; 2024 May; 47(5):1309-1322. PubMed ID: 38374239
[TBL] [Abstract][Full Text] [Related]
7. NPR-C (Natriuretic Peptide Receptor-C) Modulates the Progression of Angiotensin II-Mediated Atrial Fibrillation and Atrial Remodeling in Mice.
Jansen HJ; Mackasey M; Moghtadaei M; Liu Y; Kaur J; Egom EE; Tuomi JM; Rafferty SA; Kirkby AW; Rose RA
Circ Arrhythm Electrophysiol; 2019 Jan; 12(1):e006863. PubMed ID: 30636477
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin I
Zhang Y; Yuan M; Cai W; Sun W; Shi X; Liu D; Song W; Yan Y; Chen T; Bao Q; Zhang B; Liu T; Zhu Y; Zhang X; Li G
Cell Mol Life Sci; 2024 Jun; 81(1):264. PubMed ID: 38878214
[TBL] [Abstract][Full Text] [Related]
9. UCHL1, a deubiquitinating enzyme, regulates lung endothelial cell permeability in vitro and in vivo.
Mitra S; Epshtein Y; Sammani S; Quijada H; Chen W; Bandela M; Desai AA; Garcia JGN; Jacobson JR
Am J Physiol Lung Cell Mol Physiol; 2021 Apr; 320(4):L497-L507. PubMed ID: 33438509
[TBL] [Abstract][Full Text] [Related]
10. LOXL2 Inhibitor Attenuates Angiotensin II-Induced Atrial Fibrosis and Vulnerability to Atrial Fibrillation through Inhibition of Transforming Growth Factor Beta-1 Smad2/3 Pathway.
Wu Y; Can J; Hao S; Qiang X; Ning Z
Cerebrovasc Dis; 2022; 51(2):188-198. PubMed ID: 34515064
[TBL] [Abstract][Full Text] [Related]
11. H
Lu G; Xu C; Tang K; Zhang J; Li Q; Peng L; Wang Y; Huang Z; Gao X
Biochem Biophys Res Commun; 2017 Jan; 483(1):534-540. PubMed ID: 28011270
[TBL] [Abstract][Full Text] [Related]
12. Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury.
Yagi S; Akaike M; Aihara K; Ishikawa K; Iwase T; Ikeda Y; Soeki T; Yoshida S; Sumitomo-Ueda Y; Matsumoto T; Sata M
Hypertension; 2010 Apr; 55(4):918-23. PubMed ID: 20194307
[TBL] [Abstract][Full Text] [Related]
13. SHP-1 alleviates atrial fibrosis in atrial fibrillation by modulating STAT3 activation.
Zang X; Zhao Z; Chen K; Song W; Ma J; Fu H; Wang X; Zhao Y
Exp Biol Med (Maywood); 2023 Jun; 248(11):979-990. PubMed ID: 37226737
[TBL] [Abstract][Full Text] [Related]
14. UCHL1 inhibition attenuates cardiac fibrosis via modulation of nuclear factor-κB signaling in fibroblasts.
Gong Z; Ye Q; Wu JW; Zhou JL; Kong XY; Ma LK
Eur J Pharmacol; 2021 Jun; 900():174045. PubMed ID: 33745956
[TBL] [Abstract][Full Text] [Related]
15. MFGE8 attenuates Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation through inhibition of TGF-β1/Smad2/3 pathway.
Ge Z; Chen Y; Wang B; Zhang X; Yan Y; Zhou L; Zhang Y; Xie Y
J Mol Cell Cardiol; 2020 Feb; 139():164-175. PubMed ID: 31958465
[TBL] [Abstract][Full Text] [Related]
16. Platelets Promote Ang II (Angiotensin II)-Induced Atrial Fibrillation by Releasing TGF-β1 (Transforming Growth Factor-β1) and Interacting With Fibroblasts.
Liu Y; Lv H; Tan R; An X; Niu XH; Liu YJ; Yang X; Yin X; Xia YL
Hypertension; 2020 Dec; 76(6):1856-1867. PubMed ID: 33175633
[TBL] [Abstract][Full Text] [Related]
17. Adipose Triglyceride Lipase Deficiency Aggravates Angiotensin II-Induced Atrial Fibrillation by Reducing Peroxisome Proliferator-Activated Receptor α Activation in Mice.
Han X; Zhang YL; Zhao YX; Guo SB; Yin WP; Li HH
Lab Invest; 2023 Jan; 103(1):100004. PubMed ID: 36748188
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of UCHL1 are a compensatory response to disrupted ubiquitin homeostasis in spinal muscular atrophy and do not represent a viable therapeutic target.
Powis RA; Mutsaers CA; Wishart TM; Hunter G; Wirth B; Gillingwater TH
Neuropathol Appl Neurobiol; 2014 Dec; 40(7):873-87. PubMed ID: 25041530
[TBL] [Abstract][Full Text] [Related]
19. Chemokine Receptor CXCR-2 Initiates Atrial Fibrillation by Triggering Monocyte Mobilization in Mice.
Zhang YL; Cao HJ; Han X; Teng F; Chen C; Yang J; Yan X; Li PB; Liu Y; Xia YL; Guo SB; Li HH
Hypertension; 2020 Aug; 76(2):381-392. PubMed ID: 32639881
[TBL] [Abstract][Full Text] [Related]
20. MFAP4 deletion attenuates the progression of angiotensin II-induced atrial fibrosis and atrial fibrillation.
Wang H; Liu M; Wang X; Shuai W; Fu H
Europace; 2022 Feb; 24(2):340-347. PubMed ID: 34379753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
